✦ LIBER ✦

Plasma lipid lowering activity of acipimox in patients with type II and type IV hyperlipoproteinemia: Results of a multicenter trial

✍ Scribed by G. Crepaldi; P. Avogaro; G.C. Descovich; T. Di Perri; A. Postiglione; C.R. Sirtori; A. Strano; S. Ventura; L. Musatti

Book ID: 118896011
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 663 KB
Volume: 70
Category: Article
ISSN: 0021-9150
DOI: 10.1016/0021-9150(88)90105-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of oxandrolone on plasma triglyc

Effects of oxandrolone on plasma triglycerides and postheparin lipolytic activity in patients with types III, IV, and V familial hyperlipoproteinemia

✍ Charles J. Glueck 📂 Article 📅 1971 🏛 Elsevier Science 🌐 English ⚖ 912 KB

A randomized, double‐blind, multicenter,

A randomized, double‐blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis

✍ Zhang, Ling‐Ling ;Wei, Wei ;Xiao, Feng ;Xu, Jian‐Hua ;Bao, Chun‐De ;Ni, Li‐Qing 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

Beneficiary effect of dietary soy protei

Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy

✍ Azadbakht, L; Shakerhosseini, R; Atabak, S; Jamshidian, M; Mehrabi, Y; Esmaill-Z 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 63 KB

A multicenter, randomized, placebo-contr

A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes

✍ E. J. Rhee; W. Y. Lee; K. H. Yoon; S. J. Yoo; I. K. Lee; S. H. Baik; Y. K. Kim; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

Comparison of the clinical efficacy and

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial

✍ J. Braun; P. Kästner; P. Flaxenberg; J. Währisch; P. Hanke; W. Demary; U. von Hi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 3 views

Safety Profile and Metabolic Effects of

Safety Profile and Metabolic Effects of 14 Days of Treatment with DIO-902: Results of a Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial in Patients with Type 2 Diabetes Mellitus

✍ Sherwyn L. Schwartz; Marc Rendell; Andrew J. Ahmann; Asha Thomas; Carlos J. Arau 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 118 KB